Effects of fluticasone propionate inhalation on levels of arachidonic acid metabolites in patients with chronic obstructive pulmonary disease
Background: In smoking COPD patients the bronchoalveolar lavage (BAL) fluid contains high numbers of inflammatory cells. These cells might produce arachidonic acid (AA) metabolites, which contribute to inflammation and an increased bronchomotor tone.
Saved in:
Main Authors: | Gert T. Verhoeven (Author), Ingrid M. Garrelds (Author), Henk C. Hoogsteden (Author), Freek J. Zijlstra (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2001-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of fluticasone propionate on arachidonic acid metabolites in BAL-fluid and methacholine dose-response curves in non-smoking atopic asthmatics
by: S. E. Overbeek, et al.
Published: (1996) -
Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?
by: Keiichiro eAkamatsu, et al.
Published: (2011) -
Degradation rates and products of fluticasone propionate in alkaline solutions
by: Tadakazu Tokumura, et al.
Published: (2017) -
Effects of Budesonide and Fluticasone Propionate in Pediatric Asthma Patients
by: Lin-Yu Kuo, et al.
Published: (2010) -
Effect of Fluticasone propionate Aqueous Nasal Spray Treatment on Platelet Activating Factor and Eicosanoid Production By nasal Mucosa in Patients with A house Dust Mite Allergy
by: I. M. Garrelds, et al.
Published: (1994)